Nigeria has again announced 556 new cases of COVID-19, taking the total number of infections in the country to 36, 663.
The announcement was made by the Nigeria Centre for Disease Control (NCDC), the health agency saddled with this responsibility in the country.
The disclosure which was made on Sunday, July 19, showed that the new cases were recorded across 18 states.
According to the data from the NCDC, below are the 18 listed states where new COVID-19 cases were recorded:
9. Akwa Ibom-14
The records show that 15, 105 persons have been discharged, with 789 deaths recorded so far.
Meanwhile, the federal government has said that in order to address the testing deficit in Nigeria, it plans to establish one sample collection centre in every local government area in the country.
A sample collection centre has already been set up in the Federal Capital Territory (FCT), Abuja and all government hospitals in the FCT have been designated as sample collection centres.
The Secretary to the Government of the Federation (SGF) and chairman, Presidential Task Force (PTF) on COVID-19, Mr Boss Mustapha, made this known on Monday, July 13.
He reiterated that contracting COVID-19 is not a death sentence, but not presenting oneself for testing or treatment when symptoms become observable could likely lead to avoidable death.
In another report, scientists are inching closer to developing a vaccine for the coronavirus following a report which stated that a COVID-19 experimental vaccine developed by Moderna Inc was safe and provoked immune responses all patients tested in an initial safety trial.
Reuters reported that in the test conducted on Tuesday, July 14, patients who volunteered were given two doses of the vaccine.
The team which carried out the trials reported that patients showed high levels of virus-killing antibodies that exceeded the average levels seen in people who had recovered from COVID-19.
According to findings from the experiment which were also published in the New England Journal of Medicine, more than half of the volunteers experienced mild or moderate side effects like fatigue, headache, chills, muscle aches, or pain at the injection site.
Bloomberg citing the report stated that three of 14 patients given the highest dose experienced severe side effects, but said that dose is not being used in larger trials.
4 ways Nigerians are dealing with the COVID 19 lockdown | Legit TV